Ibogaine Research Pilot Program One Step Closer to Reality After Committee Vote – Denver7
The ibogaine research pilot program in Colorado marks a significant step toward clinical investigation of this psychedelic. This program focuses on addiction treatment research while addressing cardiac safety concerns. The pilot aims to establish…
Cannabidiol (CBD) Does Not Reduce Cocaine Reward in Schizophrenia Model
CBD schizophrenia substance use effects were tested in a mouse model of genetic susceptibility. The study found no reduction in cocaine reward or self-administration. These findings suggest limited efficacy of CBD for treating substance use in…
Cannabis Use in PTSD and Substance Use Disorders: Treatment Outcomes
This article reviews cannabis use PTSD substance use disorders outcomes in trauma-focused treatments. Patients with PTSD and co-occurring substance use disorders who use cannabis show meaningful benefits from trauma-focused care. Cannabis use does not…
A mixed-methods evaluation of a statewide naloxone distribution project: considerations for future implementation of opioid overdose prevention initiatives.
This study evaluates opioid overdose prevention via a statewide naloxone distribution program using mixed methods. It identifies barriers and facilitators for effective implementation. The findings support integrating naloxone access with…
Assessing Bias in Substance Use Disorder Diagnosis Related to Trauma and Genetics
This article discusses substance use disorder trauma diagnostic assessment focusing on biases in standard criteria. Childhood adversity and genetic liability influence how symptoms are reported. Understanding these biases is key to improving SUD…
Psychosocial Interventions for Substance Use Disorder: A Systematic Review of Therapeutic Approaches and Their Clinical Effectiveness.
Psychosocial interventions substance use disorder treatment are essential for effective care. This review highlights CBT and multicomponent approaches as most effective. Contingency management also shows promise for specific populations.
Endocannabinoid System Clinical Research: PTSD and SUD Insights
Cannabis use trauma is a critical factor in PTSD and substance use disorder research. Trauma-focused treatments maintain efficacy for patients using cannabis. This research supports continuing evidence-based care without delay.
Clinical Evidence on Cannabis Use and Trauma-Focused Treatment for PTSD and Substance Use
Cannabis use and trauma-focused treatment PTSD SUD evidence shows trauma-focused therapies remain effective for PTSD patients using cannabis. This meta-analysis clarifies treatment outcomes for co-occurring PTSD and substance use disorders. Understanding…
Endocannabinoid System & PTSD: Cannabis in Dual Diagnosis
Cannabis use and trauma-focused treatment are critical considerations in managing PTSD with co-occurring substance use disorders. Evidence shows trauma-focused treatments remain effective despite cannabis use. This supports continuing evidence-based care…
Study Finds Veterans With SUD Use Cannabis to Alleviate Pain and Anxiety
New research highlights cannabis veterans substance use disorder as a tool to manage pain, anxiety, and sleep issues. Veterans with SUD often turn to cannabis during treatment for safer symptom relief. This study supports integrating cannabis…
